Daniel Cermeno
Our team took the challenge of integrating a bioprinting system within a hospital setting, and we were fortunate to find Regemat 3D as the only company being able to adapt their system to all our diverse necessities. Their bioprinters allowed us to expand our collaborative nature, working with various research groups in the areas of skin bioprinting, bone regeneration, and 3D cancer models for drug screening. Thanks to the ability to personalize our equipment, not only we achieved optimized results for our experimental workflow, but we also discovered new scientific fields. Our research members were guided by comprehensive technical engineering assistance, during the help process, benefiting from the vast accumulated experience of bioprinting community.
